Immunotherapy has transformed cancer treatment by harnessing the body’s own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially inside tumors that actively suppress immune activity. Researchers at UCLA have now developed an implantable device that acts like a support hub for these cells, helping them stay active and continue attacking cancer. A study demonstrating the platform’s efficacy in human melanoma and lymphoma samples and laboratory cultures appears in Nature Biomedical Engineering.
This article was originally published on MedicalXpress.com
